Molecular Pathology

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Houlston, R S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Houlston, R S
J Clin Pathol: Mol Pathol 2001; 54:206-214
© 2001 Journal of Clinical Pathology


Review

What we could do now: molecular pathology of colorectal cancer

R S Houlston

Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK

Correspondence: Dr Houlston r.houlston{at}icr.ac.uk

The contribution of molecular genetics to colorectal cancer has been largely restricted to relatively rare inherited tumours and to the detection of germ line mutations predisposing to these cancers. However, much is now known about the somatic events leading to colorectal cancer in general. Several studies have examined the relation between genetic features and prognosis. The purpose of this article is to review these studies and summarise the current state of this subject. Although many of the published studies are small and inconclusive, it is clear that several different pathways exist for the development of this cancer, and some molecular characteristics seem to correlate with clinicopathological features. At present, studies are confined to evaluating a small number of molecular markers; however, with the advent of methods for the rapid genetic profiling of large numbers of colorectal cancers, it will be possible to evaluate fully the clinical usefulness of a range of colorectal cancer genotypes.

Key Words: colorectal cancer • prognosis • genes




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
E. H. Lips, R. van Eijk, E. J.R. de Graaf, P. G. Doornebosch, N. F.C.C. de Miranda, J. Oosting, T. Karsten, P. H.C. Eilers, R. A.E.M. Tollenaar, T. van Wezel, et al.
Progression and Tumor Heterogeneity Analysis in Early Rectal Cancer
Clin. Cancer Res., February 1, 2008; 14(3): 772 - 781.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Provenzani, R. Fronza, F. Loreni, A. Pascale, M. Amadio, and A. Quattrone
Global alterations in mRNA polysomal recruitment in a cell model of colorectal cancer progression to metastasis
Carcinogenesis, July 1, 2006; 27(7): 1323 - 1333.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
G. Lanza, R. Gafa, A. Santini, I. Maestri, L. Guerzoni, and L. Cavazzini
Immunohistochemical Test for MLH1 and MSH2 Expression Predicts Clinical Outcome in Stage II and III Colorectal Cancer Patients
J. Clin. Oncol., May 20, 2006; 24(15): 2359 - 2367.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Krajewska, H. Kim, C. Kim, H. Kang, K. Welsh, S.-i. Matsuzawa, M. Tsukamoto, R. G. Thomas, N. Assa-Munt, Z. Piao, et al.
Analysis of Apoptosis Protein Expression in Early-Stage Colorectal Cancer Suggests Opportunities for New Prognostic Biomarkers
Clin. Cancer Res., August 1, 2005; 11(15): 5451 - 5461.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Wang and R. A. Bambara
Human Bloom Protein Stimulates Flap Endonuclease 1 Activity by Resolving DNA Secondary Structure
J. Biol. Chem., February 18, 2005; 280(7): 5391 - 5399.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Frattini, D. Balestra, S. Suardi, M. Oggionni, P. Alberici, P. Radice, A. Costa, M. G. Daidone, E. Leo, S. Pilotti, et al.
Different Genetic Features Associated with Colon and Rectal Carcinogenesis
Clin. Cancer Res., June 15, 2004; 10(12): 4015 - 4021.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. S. Williams, R. B. Gaynor, S. Scoggin, U. Verma, T. Gokaslan, C. Simmang, J. Fleming, D. Tavana, E. Frenkel, and C. Becerra
Identification and Validation of Genes Involved in the Pathogenesis of Colorectal Cancer Using cDNA Microarrays and RNA Interference
Clin. Cancer Res., March 1, 2003; 9(3): 931 - 946.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
N J Maughan and P Quirke
Pathology - a molecular prognostic approach: Advances in colorectal cancer
Br. Med. Bull., December 1, 2002; 64(1): 59 - 74.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
S. A. LAMPRECHT and M. LIPKIN
Cellular Mechanisms of Calcium and Vitamin D in the Inhibition of Colorectal Carcinogenesis
Ann. N.Y. Acad. Sci., December 1, 2001; 952(1): 73 - 87.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
I Tomlinson
Molecular pathology of solid tumours: translating research into clinical practice. Introduction and overview
Mol. Pathol., August 1, 2001; 54(4): 201 - 202.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Molecular Pathology Journal of Clinical Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2001 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.